Works about ATAZANAVIR


Results: 442
    1
    2
    3

    Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa.

    Published in:
    Skin Pharmacology & Physiology, 2021, v. 34, n. 4, p. 167, doi. 10.1159/000513260
    By:
    • Rathner, Adriana;
    • Rathner, Petr;
    • Friedrich, Andreas;
    • Wießner, Michael;
    • Kitzler, Christian Manuel;
    • Schernthaner, Jan;
    • Karl, Thomas;
    • Krauß, Jan;
    • Lottspeich, Friedrich;
    • Mewes, Werner;
    • Hintner, Helmut;
    • Bauer, Johann W.;
    • Breitenbach, Michael;
    • Müller, Norbert;
    • Breitenbach-Koller, Hannelore;
    • von Hagen, Jörg
    Publication type:
    Article
    4
    5

    Intestinal enzymatic metabolism of drugs.

    Published in:
    Journal of Pharmacy & Pharmacology, 2011, v. 63, n. 3, p. 392, doi. 10.1111/j.2042-7158.2010.01224.x
    By:
    • Sarti, Federica;
    • Barthelmes, Jan;
    • Iqbal, Javed;
    • Hintzen, Fabian;
    • Bernkop-Schnürch, Andreas
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Amphetamine alters an EEG marker of reward processing in humans and mice.

    Published in:
    Psychopharmacology, 2022, v. 239, n. 3, p. 923, doi. 10.1007/s00213-022-06082-z
    By:
    • Cavanagh, James F.;
    • Olguin, Sarah L.;
    • Talledo, Jo A.;
    • Kotz, Juliana E.;
    • Roberts, Benjamin Z.;
    • Nungaray, John A.;
    • Sprock, Joyce;
    • Gregg, David;
    • Bhakta, Savita G.;
    • Light, Gregory A.;
    • Swerdlow, Neal R.;
    • Young, Jared W.;
    • Brigman, Jonathan L.
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.

    Published in:
    International Journal of STD & AIDS, 2012, v. 23, n. 7, p. 459, doi. 10.1258/ijsa.2012.011391
    By:
    • Bucciardini, R.;
    • D'Ettorre, G.;
    • Baroncelli, S.;
    • Ceccarelli, G.;
    • Parruti, G.;
    • Weimer, L. E.;
    • Fragola, V.;
    • Galluzzo, C. M.;
    • Pirillo, M. F.;
    • Lucattini, S.;
    • Bellagamba, R.;
    • Francisci, D.;
    • Ladisa, N.;
    • Antoni, A. Degli;
    • Guaraldi, G.;
    • Manconi, P. E.;
    • Vullo, V.;
    • Preziosi, R.;
    • Cirioni, O.;
    • Verucchi, G.
    Publication type:
    Article
    22
    23
    24
    25
    26

    Cobicistat Versus Ritonavir as a Pharmacoenhancer of Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naive HIV Type 1–Infected Patients: Week 48 Results.

    Published in:
    Journal of Infectious Diseases, 2013, v. 208, n. 1, p. 32, doi. 10.1093/infdis/jit122
    By:
    • Gallant, Joel E.;
    • Koenig, Ellen;
    • Andrade-Villanueva, Jaime;
    • Chetchotisakd, Ploenchan;
    • DeJesus, Edwin;
    • Antunes, Francisco;
    • Arastéh, Keikawus;
    • Moyle, Graeme;
    • Rizzardini, Giuliano;
    • Fehr, Jan;
    • Liu, Yapei;
    • Zhong, Lijie;
    • Callebaut, Christian;
    • Szwarcberg, Javier;
    • Rhee, Martin S.;
    • Cheng, Andrew K.
    Publication type:
    Article
    27
    28
    29

    Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings.

    Published in:
    PLoS Medicine, 2012, v. 9, n. 8, p. 1, doi. 10.1371/journal.pmed.1001290
    By:
    • Campbell, Thomas B.;
    • Smeaton, Laura M.;
    • Kumarasamy, N.;
    • Flanigan, Timothy;
    • Klingman, Karin L.;
    • Firnhaber, Cynthia;
    • Grinsztejn, Beatriz;
    • Hosseinipour, Mina C.;
    • Kumwenda, Johnstone;
    • Lalloo, Umesh;
    • Riviere, Cynthia;
    • Sanchez, Jorge;
    • Melo, Marineide;
    • Supparatpinyo, Khuanchai;
    • Tripathy, Srikanth;
    • Martinez, Ana I.;
    • Nair, Apsara;
    • Walawander, Ann;
    • Moran, Laura;
    • Yun Chen
    Publication type:
    Article
    30
    31
    32
    33
    34

    Antenatal Atazanavir: A Retrospective Analysis of Pregnancies Exposed to Atazanavir.

    Published in:
    Infectious Diseases in Obstetrics & Gynecology, 2014, p. 1, doi. 10.1155/2014/961375
    By:
    • Samuel, Miriam;
    • Bradshaw, Daniel;
    • Perry, Melissa;
    • Chan, Sum Yee;
    • Dhairyawan, Rageshri;
    • Byrne, Laura;
    • Smith, Katherine;
    • Zhou, Judith;
    • Short, Charlotte Eve;
    • Naftalin, Claire;
    • Offodile, Ngozi;
    • Mandalia, Sundhiya;
    • Roedling, Sherie;
    • Shah, Rimi;
    • Brook, Gary;
    • Poulton, Mary;
    • Rodgers, Mette;
    • Sarner, Liat;
    • Noble, Heather;
    • Hay, Philip
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50